慢性萎缩性胃炎中西医研究进展
Progress in Traditional Chinese and Western Medicine in Chronic Atrophic Gastritis
DOI: 10.12677/md.2024.143036, PDF,   
作者: 王伯妹, 汪朝景, 李富军, 张 洁:西秀区旧州医疗次中心(旧州镇卫生院)中医科,贵州 安顺;陆廷飞*:贵州中医药大学第一临床医学院,贵州 贵阳
关键词: 慢性萎缩性胃炎中西医结合研究进展Chronic Atrophic Gastritis Integrated Traditional Chinese and Western Medicine Research Progress
摘要: 慢性萎缩性胃炎(chronic atrophic gastritis, CAG)是慢性胃炎的一种类型,系指胃黏膜上皮遭受反复损害导致固有腺体的减少,伴或不伴肠腺化生和(或)假幽门腺化生的一种慢性胃部疾病。大多数该病患者无特异性临床表现,多因中上腹部不适、餐后饱胀、口苦、烧心、泛酸等症就诊,行胃镜、病理检查后方才确诊。世界卫生组织(WHO)早在多年前就指出了CAG属于胃癌的癌前状态,其中若是伴有肠化或不典型增生,癌变风险则会进一步增加。相关研究表明国外CAG的癌变率为8.6%~13.8%,而我国CAG的癌变率为1.2%~7.1%。不同地域饮食结构及生活习惯各有不同,饮食偏嗜、喜好烟酒浓茶、熬夜、各方面压力等均可导致胃肠疾病的发生发展,目前CAG的检出率也呈现逐渐上升趋势,而CAG作为胃癌的癌前状态,不得不引起我们的注意。CAG患者多为老年人,近50%胃黏膜存在萎缩改变的为50岁以上老年人,70%在40岁以上。国外研究发现,如南美、东亚、东欧等胃癌高发地,CAG的检出率也是居高不下的。荷兰通过10年对92,250例胃癌前病变患者进行随访发现肠化和萎缩性胃炎的胃癌发生率0.25/年和0.1%/年。国内研究调查发现,CAG患者主要集中于广西、福建、黑龙江等地,该病检出率约占胃镜检查的7.5%~13.8%。青海省人民医院消化内科通过研究本院187例胃镜检查报告显示:青海地区CAG发生率显著高于平原地区,胃镜室所检病种中CAG构成比高达72.47%,CAG发病率随年龄增长而增加。故探讨慢性萎缩性胃炎的研究进展至关重要,本文从中西医结合的角度论述慢性萎缩性胃炎的研究进展,为临床科研提供相应的帮助。
Abstract: Chronic atrophic gastritis (chronic atrophic gastritis, CAG) is a type of chronic gastritis, which refers to a chronic gastric disease leading to the reduction of native glands, with or without intestinal metaplasia and (or) pseudopyloric metaplasia. Most of the patients with this disease do not have specific clinical manifestations, and are usually due to middle and upper abdominal discomfort, postprandial fullness, bitter mouth, heartburn, pantothenic acid and other diseases, which are confirmed after gastroscopy and pathological examination. The World Health Organization (WHO) pointed out that CAG is a precancerous state of gastric cancer many years ago, where the risk of cancer is accompanied by enterization or atypical hyperplasia. Related studies show that the cancer rate of CAG abroad is 8.6%~13.8%, while the cancer rate of CAG in China is 1.2%~7.1%. Different regions have different dietary structure and living habits, including preference for eating, tobacco, alcohol and tea, staying up late, and all aspects of pressure can lead to the occurrence and development of gastrointestinal diseases. At present, the detection rate of CAG is also gradually rising trend, and CAG, as a precancerous state of gastric cancer, has to attract our attention. Most of the CAG patients are elderly, nearly 50% of the gastric mucosa is over 50 years old, and 70% are over 40 years old. Foreign studies have found that the detection rate of CAG in the high incidence of gastric cancer in South America, East Asia and Eastern Europe, is also high. In the Netherlands, 92,250 patients with precancerous gastric lesions for 10 years found enteric and atrophic gastric gastritis incidence 0.25/year and 0.1%/year. Domestic research found that CAG patients are mainly concentrated in Guangxi, Fujian, Heilongjiang and other places, and the detection rate of this disease accounts for about 7.5%~13.8% of gastroscopy. Through the study of the gastroscopy report of 187 cases, the incidence of CAG in Qinghai was significantly higher than that in the plain area, the composition ratio of CAG in the gastroscopy room was as high as 72.47%, and the incidence of CAG increased with the increase of age. Therefore, it is very important to discuss the research progress of chronic atrophic gastritis. This paper discusses the research progress of chronic atrophic gastritis from the perspective of combining traditional Chinese and western medicine, and provides corresponding help for clinical scientific research.
文章引用:王伯妹, 汪朝景, 李富军, 张洁, 陆廷飞. 慢性萎缩性胃炎中西医研究进展[J]. 医学诊断, 2024, 14(3): 241-248. https://doi.org/10.12677/md.2024.143036

参考文献

[1] 中华医学会消化病分会. 中国慢性胃炎共识意见(2017年, 上海) [J]. 胃肠病学, 2017, 22(11): 670-687.
[2] Valle, J., Kekki, M., Sipponen, P., Ihamäki, T. and Siurala, M. (1996) Long-Term Course and Consequences of Helicobacter pylori Gastritis Results of a 32-Year Follow-Up Study. Scandinavian Journal of Gastroenterology, 31, 546-550. [Google Scholar] [CrossRef] [PubMed]
[3] 王仲略, 周刚, 沈慧琳. 慢性萎缩性胃炎患者的危险因素与临床治疗效果[J]. 中华医院感染学杂志, 2015, 25(8): 1817-1819.
[4] Matsuhisa, T., Arakawa, T., Watanabe, T., Tokutomi, T., Sakurai, K., Okamura, S., et al. (2013) Relation between Bile Acid Reflux into the Stomach and the Risk of Atrophic Gastritis and Intestinal Metaplasia: A Multicenter Study of 2283 Cases. Digestive Endoscopy, 25, 519-525. [Google Scholar] [CrossRef] [PubMed]
[5] 杨鸿, 侯家玉. 胆汁反流致慢性萎缩性胃炎的实验研究[J]. 北京中医药大学学报, 2001, 24(5): 26-28.
[6] Mowat, A.M. and Agace, W.W. (2014) Regional Specialization within the Intestinal Immune System. Nature Reviews Immunology, 14, 667-685. [Google Scholar] [CrossRef] [PubMed]
[7] 刘跃平, 柳茂森, 朱临江, 等. 慢性萎缩性胃炎胃粘膜免疫相关指标变化研究[J]. 中国预防医学杂志, 2017, 18(1): 39-43.
[8] 王建国. 影响慢性胃炎发展为胃癌的相关因素分析[J]. 海南医学, 2015, 26(18): 2694-2696.
[9] 中国中西医结合学会消化系统疾病专业委员会. 慢性萎缩性胃炎中西医结合诊疗共识意见(2017) [J]. 中国中西医结合消化杂志, 2018, 26(2): 121-131.
[10] Dixon, M.F., Genta, R.M., Yardley, J.H. and Correa, P. (1996) Classification and Grading of Gastritis. The American Journal of Surgical Pathology, 20, 1161-1181. [Google Scholar] [CrossRef] [PubMed]
[11] 中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组, 全国幽门螺杆菌研究协作组, 刘文忠, 谢勇, 陆红, 等. 第五次全国幽门螺杆菌感染处理共识报告[J]. 胃肠病学, 2017, 22(6): 346-360.
[12] 李建根. 慢性萎缩性胃炎的病机探讨及治疗体会[J]. 四川中医, 2010, 28(10): 37-38.
[13] 王丽华, 单兆伟. 单兆伟慢性萎缩性胃炎诊疗经验浅探[J]. 辽宁中医杂志, 2015, 42(6): 1194-1195.
[14] 黄大未, 杨晋翔, 魏玥, 等. 中国南北方地区慢性萎缩性胃炎中医证候对比研究[J]. 北京中医药大学学报, 2013, 36(11): 783-785.
[15] 赵晓丹, 孙静晶, 周斌. 慢性萎缩性胃炎中医证型分布规律环球[J]. 中医药, 2015, 8(1): 18-21.
[16] 安贺军, 张波, 郭雁冰, 朱宏, 许继宗. 172例慢性萎缩性胃炎患者体质类型分析[J]. 成都中药大学学报, 2015, 38(2): 62-64.
[17] 陈泽慧, 杨晋翔, 韩海啸, 等. 258例慢性萎缩性胃炎患者中医体质类型探究[J]. 世界中西医结合杂志, 2018, 13(7): 973-976.
[18] 李志民, 于家军. 李寿山教授治疗治疗慢性萎缩性胃炎癌前病变经[J]. 中国中西医结合消化杂志, 2004, 12(3): 166.
[19] 韩文功. 辨证治疗慢性萎缩性胃炎65例[J]. 实用中医内科杂志, 2008, 22(6): 38.
[20] 许先锋. 胃复春治疗萎缩性胃炎伴肠化患者的临床效果观察[J]. 临床合理用药, 2018, 11(8): 38-40.
[21] 王伟民, 张志勇. 摩罗丹和荆花胃康与雷贝拉唑三联疗法对慢性萎缩性胃炎患者伴Hp感染的疗效及其对病理组织学改善作用的影响[J]. 抗感染药学, 2018, 15(4): 644-646.
[22] 李多, 刘德清, 齐维娟, 等. 枳术宽中胶囊联合西药治疗幽门螺杆菌阳性慢性萎缩性胃炎的临床观察[J]. 中国临床医生杂志, 2018, 46(9): 1117-1120.
[23] 陆斌, 吴旭, 赖仁胜, 等. 穴位注射对慢性萎缩性胃炎患者胃黏膜肠化的影响[J]. 江苏中医药, 2008, 40(11): 75-76.